NDC 17856-1122-01 - MAX relief junior Grape
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-1122
- Requested NDC
- 17856-1122-01
- Package NDCs from labels
- 17856-1122-5, 17856-1122-1, 17856-1122-8, 17856-1122-4, 17856-1122-6, 17856-1122-2, 17856-1122-7, 17856-1122-3, 17856-1122-9, 17856-1122-01
- Manufacturer
- ATLANTIC BIOLOGICALS CORP.
- Effective date
- 2026-02-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| MAX relief junior Grape - ATLANTIC BIOLOGICALS CORP. | ATLANTIC BIOLOGICALS CORP. | 2026-02-13 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-1122-1 | MAX relief junior Grape | 50 in 1 BOX, UNIT-DOSE | LIQUID | 50 | 4 | |
| 17856-1122-2 | MAX relief junior Grape | 120 in 1 BOX, UNIT-DOSE | LIQUID | 120 | 4 | |
| 17856-1122-3 | MAX relief junior Grape | 120 in 1 BOX, UNIT-DOSE | LIQUID | 120 | 4 | |
| 17856-1122-4 | MAX relief junior Grape | 72 in 1 BOX, UNIT-DOSE | LIQUID | 72 | 4 | |
| 17856-1122-5 | MAX relief junior Grape | 20.3 mL in 1 CUP, UNIT-DOSE | LIQUID | 20.3 | 4 | |
| 17856-1122-6 | MAX relief junior Grape | 1.25 mL in 1 SYRINGE | LIQUID | 1.25 | 4 | |
| 17856-1122-7 | MAX relief junior Grape | 2.5 mL in 1 SYRINGE | LIQUID | 2.5 | 4 | |
| 17856-1122-8 | MAX relief junior Grape | 15 mL in 1 CUP, UNIT-DOSE | LIQUID | 15 | 4 | |
| 17856-1122-9 | MAX relief junior Grape | 60 in 1 BOX, UNIT-DOSE | LIQUID | 60 | 4 | |
| 17856-1122-9 | MAX relief junior Grape | 1 mL in 1 SYRINGE | LIQUID | 1 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-1122 | MAX RELIEF JUNIOR GRAPE (CHILDRENS ACETAMINOPHEN) LIQUID [ATLANTIC BIOLOGICALS CORP.] | 3 | Current NDC, 10 package rows | 20250514_562d7901-44d6-4d9b-be8b-a8d468a22c43.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 17856-1122-1 | ML - Milliliter | 17856-1122 | 6ff0a9b2-03be-4ea1-8611-39fbd5be4f4b | 1 | 2026-02-05 |
| 17856-1122-5 | ML - Milliliter | 17856-1122 | 8df3891c-73a2-47c4-bcee-72eea1317e38 | 1 | 2026-03-17 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Acetaminophen | ACETAMINOPHEN | Marlex Pharmaceuticals Inc | 4a183b7d-3a1e-5557-e063-6294a90a5493 | 2026-02-01 | Warnings | M013 362O9ITL9D |
| cold and flu | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE | HyVee Inc | 5110526f-51fd-401e-ba52-520674d34f37 | 2026-02-01 | Warnings | 362O9ITL9D |
| Optase | GLYCERIN | Scope Health Inc | 376e0289-28e9-e87f-e063-6294a90a3b04 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 10c3e31d-779d-8ff6-e063-6294a90acd39 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 9e96976b-2990-79e0-e053-2995a90a0f29 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | d81c1a4f-87b0-ee8c-e053-2995a90af9e5 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | f452a2c4-c869-7bf5-e053-2995a90ac1a0 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Migraine Relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Family Dollar (FAMILY WELLNESS) | bfcffa70-94a9-43de-9f22-4ed6a71c0a8d | 2026-01-29 | Warnings | 362O9ITL9D |
| Regener-Eyes Ophthalmic Solution LITE XL | GLYCERIN OPHTHALMIC SOLUTION | M & M PRODUCTS, L.L.C. | 47ab9609-4291-30b2-e063-6394a90a421e | 2026-01-29 | Warnings | PDC6A3C0OX |
| Regener-Eyes Ophthalmic Solution PROFESSIONAL STRENGTH XL | GLYCERIN OPHTHALMIC SOLUTION | M & M PRODUCTS, L.L.C. | 48d6dc98-66e8-b499-e063-6394a90ae935 | 2026-01-29 | Warnings | PDC6A3C0OX |
| EXTRA STRENGTH PAIN RELEIF | ACETAMINOPHEN | Strategic Sourcing Services, LLC | 0392db17-c4f3-424b-9dee-549fc5df61c5 | 2026-01-29 | Warnings | M013 362O9ITL9D |
| Regular Strength Pain Reliever | ACETAMINOPHEN | Strategic Sourcing Services, LLC | 959db1b0-2d9f-4857-b475-0fa027365212 | 2026-01-29 | Warnings | M013 362O9ITL9D |
| ASPIRIN | ASPIRIN | Strategic Sourcing Services LLC | 8acdbcf9-64a0-4dda-b60e-7e122254ecf3 | 2026-01-29 | Warnings | M013 |
| Optase | GLYCERIN | Scope Health Inc | 86c14327-ffc7-806e-e053-2991aa0aaf92 | 2026-01-29 | Warnings | PDC6A3C0OX |
| Night Time Cold and Flu ReadyInCase | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE | P & L Development, LLC | e7dd763b-3005-4723-933b-171eb772afee | 2026-01-29 | Warnings | 362O9ITL9D |
| Acetaminophen Extra Strength | ACETAMINOPHEN | FOODHOLD U.S.A., LLC | bc19bd47-69ea-4bcc-8d28-c043c9d32513 | 2026-01-29 | Warnings | M013 362O9ITL9D |
| Acetaminophen, Guaifenesin, Phenylephrine Hcl and Dextromethorphan HBr | ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HCL AND DEXTROMETHORPHAN HBR | Softgel Healthcare Pvt Ltd | 24bc9ae6-8e8f-c0a0-e063-6394a90a407f | 2026-01-28 | Warnings | 362O9ITL9D |
| Acetaminophen, Dextromethorphan Hydrobromide and Doxylamine Succinate | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE AND DOXYLAMINE SUCCINATE | Softgel Healthcare Private Limited | 229d1939-84a9-f18e-e063-6394a90aba30 | 2026-01-28 | Warnings | 362O9ITL9D |
| Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate and Phenylephrine Hydrochloride | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE AND PHENYLEPHRINE HYDROCHLORIDE | SOFTGEL HEALTHCARE PRIVATE LIMITED | 1fcbafaa-c871-db6d-e063-6394a90aab5e | 2026-01-28 | Warnings | 362O9ITL9D |
| Acetaminophen, Dextromethorphan Hydrobromide and Phenylephrine Hydrochloride | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE AND PHENYLEPHRINE HYDROCHLORIDE | SOFTGEL HEALTHCARE PRIVATE LIMITED | 1f7a6375-ab66-9782-e063-6394a90a99f3 | 2026-01-28 | Warnings | 362O9ITL9D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.